Академический Документы
Профессиональный Документы
Культура Документы
1 of 3
http://www.pharmaceutical-journal.com/opinion/qa/qa-the-story-on-the...
Public health
David Heymann talks about the Zika virus and microcephaly, the
latest global public health emergency, and what is being done to
tackle it.
David Heymann is chair of the International Health Regulations emergency committee. He is also
professor of infectious disease epidemiology at London School of Hygiene and Tropical
Medicine, the head of the Centre on Global Health Security at Chatham House, London, and
chairman of Public Health England. Previously he was the World Health Organization (WHO)
assistant director general for health security and environment, and representative of the director
general for polio eradication.
From 1998 to 2003, he was executive director of the WHO communicable diseases cluster,
during which he headed the successful global response to severe acute respiratory syndrome and,
before that, was director for the WHO programme on emerging and other communicable
diseases.
15/02/2016 12:39 AM
Q&A: The story on the Zika virus and microcephaly so far | Q&A | Ph...
2 of 3
http://www.pharmaceutical-journal.com/opinion/qa/qa-the-story-on-the...
Before joining the WHO, he worked for 13 years as a medical epidemiologist in sub-Saharan
Africa, on assignment from the US Centers for Disease Control and Prevention (CDC), where he
participated in the first and second outbreaks of Ebola haemorrhagic fever, and supported
ministries of health in research aimed at better control of malaria, measles, tuberculosis and other
infectious diseases.
On 1 February 2016 WHO director general Margaret Chan declared that the recent cluster of
microcephaly cases and other neurological disorders reported in Brazil, following a similar
cluster in French Polynesia in 2014, constitutes a public health emergency of international
concern.
What are your aims now that a public health emergency has been called
for microcephaly?
Because the public health emergency was called for the microcephaly instead of the Zika virus,
we can do better surveillance and understand which countries that have a Zika outbreak also
have microcephaly and other disorders. This requires a standardised case definition and
collaborative efforts to determine whether or not there is a link between the microcephaly and the
virus.
The precautionary measures are for Zika because its a virus like dengue or chikungunya, and
they require vector control [any method to limit or eradicate the mammals, birds, insects or other
arthropods vectors which transmit disease pathogens]. We need to understand how
infection occurs in order to prevent it from happening, and we need to consider whether a vaccine
could be developed. So the precautionary measures are on the virus, whereas the urgency and
emergency measures are on the microcephaly.
The WHO has said that up to 4 million people could be infected with Zika
in the Americas, of which 1.5 million alone will be in Brazil. What about
the rest of the world? Are they also at risk?
The virus is already known to circulate in Africa and in Asia. It is known to have been in India
also. Now it has made it to Latin America. So really it has just been travelling around the world.
15/02/2016 12:39 AM
Q&A: The story on the Zika virus and microcephaly so far | Q&A | Ph...
3 of 3
http://www.pharmaceutical-journal.com/opinion/qa/qa-the-story-on-the...
How far off are we from an effective vaccine, given there is no effective
vaccine against Dengue, which the same vector the yellow fever
mosquito spread?
Its not clear how far off we are from a vaccine. But there first has to be basic research to develop
the strains that go into a vaccine. Then it has to be tested in the animal model and, if it has been
shown to be safe and effective in an animal, then it goes into safety and effectiveness studies in
humans. So, were probably talking about years after the initial development is done.
Do you think you will need to rally resources like we saw in the Ebola
outbreak?
In this case, different types of resources have to be mobilised compared with Ebola. We need
money to take care of vector control, and we need money for research to determine whether or
not theres a linkage between the virus and microcephaly.
15/02/2016 12:39 AM